Govt approves Wage Revision & Pension Revision for PSGICs, NABARD and RBI (See 'Corp Brief') ICAR-Borlaug Institute jointly organise NICRA Review and ACASA-India Launch Workshop (See 'Corp Brief') Sundays on Cycle to celebrate National Voters' Day through #MYBharatMYVote (See 'Corp Brief') India is Partner Country at Gulfood 2026 for First Time (See 'Corp Brief') NHA Organizes Federated Intelligence Hackathon for Healthcare at IIT Kanpur (See 'Corp Brief') Trade Mark - permanent injunction allowed on use of certain Trade Mark, which is visually, phonetically & structurally similar to an existing trade mark, which also has considerable goodwill: HC (See 'Legal Desk') NIFT Conference 2026 on 'Design for Inclusive Futures' Opens at NIFT Mumbai (See 'Corp Brief') MSDE signs landmark MoU with WEF to deepen Cooperation in Vocational Education (See 'Corp Brief') Ministry of I&B Tableau showcases Vision of WAVES (See 'Corp Brief') Scindia chairs Q3 Business Review to Fast-Track India Post's transformation (See 'Corp Brief') IBC - Valuation report submitted by RV serves as critical document for Committee of Creditors to take crucial decision about resolution plan in CIRP and reserve price of asset during liquidation: IBBI (See 'Legal Desk') CMD, IREDA Highlights India's Solar Leadership at WEF (See 'Corp Brief') Cotton Corporation hands over Rs 8.9 Cr dividend to Textiles Minister (See 'Corp Brief') India to showcase AI Impact, Sovereign Models and Safety Frameworks (See 'Corp Brief') CTIL, NLU Odisha organize Conference on Role of Trade in Global Energy Transition (See 'Corp Brief') IBC - If attachment action may jeopardise resolution plan and cause grave prejudice to interest of homebuyers, matter needs further consideration: HC (See 'Legal Desk') MoPNG organises High-Level Upstream Engagements on Financing & Regulatory Reforms (See 'Corp Brief') NHAI, Konkan Railway sign MoU to Strengthen Integrated Infrastructure Development (See 'Corp Brief') SAMPANN pension portal integrates with UMANG Portal (See 'Corp Brief') Patel launches NBEMS Online Training Program on AI in Medical Education (See 'Corp Brief') Trade Marks - Hermes, Birkin marks - suit for infringement allowed, as both marks are well-recognized & consistently used: HC (See 'Legal Desk') CCI embraces government monopolies and PSUs (See CORP EINSICHT) Centre releases Rs 213 Crores Grants to strengthen rural local bodies in Assam (See 'Corp Brief') Strengthening Bilateral trade and International Market Linkage for fisheries exports (See 'Corp Brief') Scindia reviews BSNL's Q3 Performance; Stresses on Quality of Service (See 'Corp Brief') CCI okays combination between Bhushan Power, JSW Sambalpur, JFE Steel and JSW Kalinga (See 'Corp Brief') Companies Act – Company Court cannot order release of assets to ex-director without adjudicating rival claims: HC (See 'Legal Desk') CCI permits Apollo Hospitals to pick up equity in Apollo Health (See 'Corp Brief') CCI approves acquisition of equity share of Thriveni Pellets by Tata Steel (See 'Corp Brief') CCI allows Emirates NBD Bank to pick up equity in RBL Bank (See 'Corp Brief') Goyal to address 65th Central Geological Programming Board Meeting in Delhi (See 'Corp Brief') PMLA - Assets derived from unlawful betting activity may be treated as proceeds of crime: HC (See 'Legal Desk') Govt's focus is on climate-smart aquaculture and efficient resource utilisation (See 'Corp Brief') Sonowal Issues Clarification on Forged Letter (See 'Corp Brief') A&C - Arbitral tribunal is legally empowered to terminate proceedings u/s 38(2) of Arbitration Act, if party fails to pay its share of arbitrator's fees: SC (See 'Legal Desk') Science ministries push thematic clustering of Startups at review meeting (See 'Corp Brief') Nearly 100 delegates from over 70 countries to participate at ECI event (See 'Corp Brief') A&C - Bill discounting is short-term, high-risk commercial financing mechanism where elevated interest rates are neither unusual nor inherently unfair: SC (See 'Legal Desk') CEA has successfully conducted 220 elections; 70 elections currently underway (See 'Corp Brief') Service Matter - Government is bound by same limitation laws as any other party; delay caused by bureaucratic procedures cannot be mechanically condoned: HC (See 'Legal Desk') Khattar inaugurates Centre of Excellence for power sector regulatory affairs at Delhi IIT (See 'Corp Brief') Misc - Civil suit seeking cancellation of a registered sale deed is barred u/s 34 of SARFAESI Act when SARFAESI measures have been initiated: HC (See 'Legal Desk') Port, Inland Waterways Projects Worth Rs 552 Crore launched to boost Riverine Logistics (See 'Corp Brief') Manjhi inaugurates PM Vishwakarma Haat 2026 in New Delhi (See 'Corp Brief') PMLA - If property is attached for value thereof to proceeds of crime, it happens when proceeds of crime acquired or obtained directly or indirectly is not available in hands of person: SAFEMA (See 'Legal Desk') AIIA celebrates National Startup Day 2026 (See 'Corp Brief') SEBI - Proposed Acquirer shall be exempted from complying with requirements of sub-regulation (1) of regulation 3 and regulation 4 of SAST Regulations, 2011 with respect to direct acquisition in Target Company: SEBI (See 'Legal Desk')

Print

MoS reaffirms India's commitment to global pharmaceutical standardization

Published: Feb 06, 2025

By TIOLCorplaws News Service

NEW DELHI, FEB 06, 2025: UNION Minister of State for Health and Family Welfare, Anupriya Patel delivered the keynote address at the 15th International Meeting of World Pharmacopoeias (IMWP), hosted by the Indian Pharmacopoeia Commission (IPC) under the aegis of the Ministry of Health and Family Welfare, Government of India, in collaboration with the World Health Organization (WHO), here today. The meeting brought together global pharmacopoeial leaders, regulatory authorities, and industry stakeholders to deliberate on key issues related to pharmaceutical standards and harmonization.

Addressing the gathering, Patel reaffirmed India's commitment to global pharmaceutical standardization and regulatory convergence. She highlighted India's role as the "Pharmacy of the World" and emphasized the importance of ensuring access to high-quality medicines globally. She stated that the IMWP serves as a vital platform to foster international collaboration in pharmacopoeial science and regulatory harmonization.

On this occasion, the Union Minister also released the IPC Newsletter 2024 and a special IPC video film, which showcase India's advancements in pharmacopoeial science and the Commission's efforts in ensuring high-quality pharmaceutical standards. The video film can be accessed at the following link: https://www.youtube.com/watch?v=MCdAZodvOSM .

Punya Salila Srivastava, Secretary, Ministry of Health and Family Welfare, underscored the significance of global partnerships in strengthening pharmaceutical quality standards. She reiterated India's efforts in aligning regulatory frameworks with international best practices and ensuring the availability of safe and effective medicines worldwide.

Dr. Rajeev Singh Raghuvanshi, Secretary-cum-Scientific Director, IPC, and Drugs Controller General (India), highlighted IPC's contributions in setting global benchmarks in pharmacopoeial science. He elaborated on IPC's initiatives, including the IP Online platform, which enhances accessibility and usability of Indian Pharmacopoeia standards. He emphasized the role of scientific advancements and regulatory cooperation in shaping global pharmaceutical standards.

Dr. Roderico H. Ofrin, WHO Representative to India, commended India's leadership in pharmacopoeial standard-setting and emphasized the importance of regulatory harmonization in ensuring patient safety and public health.

The 15th IMWP is set to facilitate discussions on key focus areas, including:

- Updates on recommendations from the 14th IMWP and review of progress on harmonization initiatives.

- Emerging issues in impurity assessment (Q3) and the implications of ICH Q6 guidelines on pharmacopoeial monograph specifications.

- Defining the IMWP Charter to establish a long-term governance structure for the forum.

- Enhancing collaboration among global pharmacopoeias and regulatory bodies, with updates from the Pharmacopoeial Discussion Group (PDG).

- Promotion of environmental sustainability in pharmacopoeial practices and pharmaceutical manufacturing standards.

- Finalization of reports for the 15th IMWP and preparatory discussions for the 16th IMWP.

The deliberations during the IMWP will reinforce the role of pharmacopoeias in ensuring the quality, safety, and efficacy of medicines. The outcomes of the meeting will guide future collaborations in standard-setting and regulatory harmonization.

The 15th IMWP, which commenced today, will conclude on 7th February 2025. The discussions held over these three days will set the stage for further strengthening global pharmacopoeial cooperation and enhancing pharmaceutical quality assurance.

TIOL CORP SEARCH

TIOL GROUP WEBSITES

taxindiaonline
taxindiainternational
tioltube
TKF
TIOLawards
A TIOL Website. Copyright © 2025 TIOLcorplaws.com All rights reserved.